Home/Filings/4/0001209191-24-001137
4//SEC Filing

Mayer Arie 4

Accession 0001209191-24-001137

CIK 0001176309other

Filed

Jan 7, 7:00 PM ET

Accepted

Jan 8, 4:34 PM ET

Size

6.8 KB

Accession

0001209191-24-001137

Insider Transaction Report

Form 4
Period: 2024-01-04
Mayer Arie
Director
Transactions
  • Award

    Common Stock

    2024-01-04+9,32596,134 total
  • Award

    Common Stock

    2024-01-04+30,00086,809 total
Footnotes (2)
  • [F1]Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 10,000 shall vest on each of January 1, 2025, January 1, 2026 and January 1, 2027. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.
  • [F2]Represents Restricted Stock Units ("RSUs") that will vest in quarterly installments of approximately 2,331 on April 1, 2024, July 1, 2024, October 1, 2024 and January 1, 2025. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Issuer

ORAMED PHARMACEUTICALS INC.

CIK 0001176309

Entity typeother

Related Parties

1
  • filerCIK 0001796583

Filing Metadata

Form type
4
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 4:34 PM ET
Size
6.8 KB